| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |